"This data gives patients the option to benefit from esketamine treatment either with or without an antidepressant," said ...

Research presented at this year's Psych Congress meeting in Boston included a randomized trial of esketamine (Spravato) ...

The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...

Brain and Cognition Discovery Foundation, Toronto, ON, Canada Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada Department of Pharmacology & Toxicology, University ...

Initial studies demonstrating rapid antidepressant effects drove research leading to the recent US Food and Drug Administration (FDA) approval of intranasal esketamine, the first (and at present, only ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

Following esketamine for TRD, PHQ-9 scores significantly reduced by 5.9 in the overall cohort and 6.0 in the TMS-naïve subgroup. Sustained use of esketamine nasal spray significantly improves ...

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

Following the arrests made in connection to Perry’s death, in an interview where CBS Face the Nation host Margaret Brennan likened ketamine abuse to the beginnings of the opioid epidemic, DEA ...

“Treatment-resistant forms of major depression are common and have large ... and suicidal thoughts. Esketamine is also being reviewed by the EMA, which is looking to make a decision later ...